Sensus Healthcare (SRTS) Net Income towards Common Stockholders (2016 - 2025)

Sensus Healthcare's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at -$3.2 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders fell 304.85% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$5.1 million (down 385.79% YoY), while the FY2025 annual figure was -$7.7 million, down 216.13% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at -$3.2 million, down from -$943000.0 in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $5.3 million in Q4 2021, with the low at -$631.3 million in Q1 2022.
• The 5-year median for Net Income towards Common Stockholders is -$42000.0 (2021), against an average of -$31.0 million.
• The sharpest annual moves came in 2021 and 2022: Net Income towards Common Stockholders jumped 1969.26% in 2021, then sank 56517.94% in 2022.
• Sensus Healthcare's Net Income towards Common Stockholders stood at $5.3 million in 2021, then slumped by 46.8% to $2.8 million in 2022, then soared by 48.82% to $4.2 million in 2023, then slumped by 63.28% to $1.5 million in 2024, then sank by 304.85% to -$3.2 million in 2025.
• Business Quant data shows SRTS's Net Income towards Common Stockholders at -$3.2 million in Q4 2025, -$943000.0 in Q3 2025, and -$1.0 million in Q2 2025.